KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Debt to Equity: 2024

Historic Debt to Equity for Esperion Therapeutics (ESPR) over the last 1 years, with Dec 2024 value amounting to -$0.36.

  • Esperion Therapeutics' Debt to Equity was N/A to -$0.34 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.34, marking a year-over-year change of. This contributed to the annual value of -$0.36 for FY2024, which is N/A change from last year.
  • Esperion Therapeutics' Debt to Equity amounted to -$0.36 in FY2024.
  • In the past 5 years, Esperion Therapeutics' Debt to Equity registered a high of -$0.36 during FY2024, and its lowest value of -$0.36 during FY2024.
  • Moreover, its 1-year median value for Debt to Equity was -$0.36 (2024), whereas its average is -$0.36.